The role of gamma-aminobutyric acid and glutamate for hypoxic ventilatory response in anesthetized rabbits.
Acute hypoxia produces an increase in ventilation. When the hypoxia is sustained, the initial increase in ventilation is followed by a decrease in ventilation. Hypoxia causes changes in brain neurotransmitters depending on its severity and durations. The purpose of this study was to investigate the role of gamma-aminobutyric acid (GABA) and glutamate for hypoxic ventilatory response in rabbits. The experiments were performed in peripheral chemoreceptors intact and denervated rabbits anesthetized with Na-pentobarbitate. For intracerebroventricular (ICV) injections of reagents in each animal, cannula was placed in left lateral cerebral ventricle by stereotaxic method. After ICV injection of GABA (0.48 mg/kg), air breathing in both groups caused a depression of respiratory activity. On the other hand, after ICV injection of GABA, breathing of hypoxic gas mixture (8% O(2)-92% N(2)) in both groups produced the hypoxic hyperventilation. After ICV injection of GABA, blockade of GABA(A) receptors with bicuculline (0.2 mg/kg) did not prevent the hypoxic hyperventilation. In contrast, after ICV GABA injection, blockade of glutamate NMDA receptors with MK-801 (0.09 mg/kg) completely abolished the hypoxic hyperventilation observed while the animals were breathing hypoxic gas mixture. Our findings suggest that ICV injection of GABA causes respiratory depression in normoxic conditions, and that it increases ventilation in hypoxic conditions with or without peripheral chemoreceptor impulses by increasing glutamate.
Yelmen
Karaturan Nermin
KN
University of Istanbul, Cerrahpasa Medical School, Department of Physiology, Istanbul, Turkey. nermink@istanbul.edu.tr
D000759:Adjuvants, Anesthesia / Q000494:pharmacology*; D000758:Anesthesia; D000818:Animals; D001011:Aorta / Q000473:pathology; D002339:Carotid Arteries / Q000473:pathology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D018757:GABA Modulators / Q000494:pharmacology*; D018698:Glutamic Acid / Q000378:metabolism / Q000502:physiology*; D000860:Hypoxia; D010100:Oxygen / Q000378:metabolism; D010424:Pentobarbital / Q000494:pharmacology; D010791:Phrenic Nerve / Q000378:metabolism; D011817:Rabbits; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism; D012119:Respiration; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D000759:Adjuvants, Anesthesia; D018691:Excitatory Amino Acid Antagonists; D018757:GABA Modulators; D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D016291:Dizocilpine Maleate; D010424:Pentobarbital; D010100:Oxygen